FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896534168> ?p ?o ?g. }

• W2896534168 endingPage "178" @default.
• W2896534168 startingPage "171" @default.
• W2896534168 abstract "Abstract The pharmacokinetic properties of the fluoroquinolone levofloxacin ( LFX ) were investigated in six dogs after single intravenous, oral and subcutaneous administration at a dose of 2.5, 5 and 5 mg/kg, respectively. After intravenous administration, distribution was rapid ( T ½dist 0.127 ± 0.055 hr) and wide as reflected by the volume of distribution of 1.20 ± 0.13 L/kg. Drug elimination was relatively slow with a total body clearance of 0.11 ± 0.03 L kg −1 hr −1 and a T ½ for this process of 7.85 ± 2.30 hr. After oral and subcutaneous administration, absorption half‐life and T max were 0.35 and 0.80 hr and 1.82 and 2.82 hr, respectively. The bioavailability was significantly higher ( p ˂ 0.05) after subcutaneous than oral administration (79.90 vs. 60.94%). No statistically significant differences were observed between other pharmacokinetic parameters. Considering the AUC 24 hr / MIC and C max / MIC ratios obtained, it can be concluded that LFX administered intravenously (2.5 mg/kg), subcutaneously (5 mg/kg) or orally (5 mg/kg) is efficacious against Gram‐negative bacteria with MIC values of 0.1 μg/ml. For Gram‐positive bacteria with MIC values of 0.5 μg/kg, only SC and PO administration at a dosage of 5 mg/kg showed to be efficacious. MIC ‐based PK / PD analysis by Monte Carlo simulation indicates that the proposed dose regimens of LFX , 5 and 7.5 mg/kg/24 hr by SC route and 10 mg/kg/24 hr by oral route, in dogs may be adequate to recommend as an empirical therapy against S. aureus strains with MIC ≤ 0.5 μg/ml and E. coli strains with MIC values ≤0.125 μg/ml." @default.
• W2896534168 created "2018-10-26" @default.
• W2896534168 creator A5005505896 @default.
• W2896534168 creator A5060663725 @default.
• W2896534168 date "2018-10-09" @default.
• W2896534168 modified "2023-10-09" @default.
• W2896534168 title "Pharmacokinetics of levofloxacin after single intravenous, oral and subcutaneous administration to dogs" @default.
• W2896534168 cites W1491580460 @default.
• W2896534168 cites W1616547678 @default.
• W2896534168 cites W1963672838 @default.
• W2896534168 cites W1963829371 @default.
• W2896534168 cites W1967816847 @default.
• W2896534168 cites W1976824086 @default.
• W2896534168 cites W1984413539 @default.
• W2896534168 cites W1997364324 @default.
• W2896534168 cites W1998793209 @default.
• W2896534168 cites W1999685352 @default.
• W2896534168 cites W2024616331 @default.
• W2896534168 cites W2026554250 @default.
• W2896534168 cites W2034697164 @default.
• W2896534168 cites W2050196678 @default.
• W2896534168 cites W2056299388 @default.
• W2896534168 cites W2059989328 @default.
• W2896534168 cites W2061670511 @default.
• W2896534168 cites W2065169226 @default.
• W2896534168 cites W2068301725 @default.
• W2896534168 cites W2069512513 @default.
• W2896534168 cites W2070050941 @default.
• W2896534168 cites W2089087883 @default.
• W2896534168 cites W2089801271 @default.
• W2896534168 cites W2090004349 @default.
• W2896534168 cites W2090214881 @default.
• W2896534168 cites W2095926637 @default.
• W2896534168 cites W2101359892 @default.
• W2896534168 cites W2104056342 @default.
• W2896534168 cites W2113973140 @default.
• W2896534168 cites W2115215601 @default.
• W2896534168 cites W2129103930 @default.
• W2896534168 cites W2137545422 @default.
• W2896534168 cites W2137961454 @default.
• W2896534168 cites W2138702913 @default.
• W2896534168 cites W2148911390 @default.
• W2896534168 cites W2152510108 @default.
• W2896534168 cites W2158414005 @default.
• W2896534168 cites W2158703436 @default.
• W2896534168 cites W2159252586 @default.
• W2896534168 cites W2168175751 @default.
• W2896534168 cites W2171653766 @default.
• W2896534168 cites W2502670554 @default.
• W2896534168 cites W2578797650 @default.
• W2896534168 doi "https://doi.org/10.1111/jvp.12726" @default.
• W2896534168 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30302775" @default.
• W2896534168 hasPublicationYear "2018" @default.
• W2896534168 type Work @default.
• W2896534168 sameAs 2896534168 @default.
• W2896534168 citedByCount "10" @default.
• W2896534168 countsByYear W28965341682019 @default.
• W2896534168 countsByYear W28965341682020 @default.
• W2896534168 countsByYear W28965341682021 @default.
• W2896534168 countsByYear W28965341682023 @default.
• W2896534168 crossrefType "journal-article" @default.
• W2896534168 hasAuthorship W2896534168A5005505896 @default.
• W2896534168 hasAuthorship W2896534168A5060663725 @default.
• W2896534168 hasConcept C110121322 @default.
• W2896534168 hasConcept C112705442 @default.
• W2896534168 hasConcept C121332964 @default.
• W2896534168 hasConcept C125287762 @default.
• W2896534168 hasConcept C134306372 @default.
• W2896534168 hasConcept C139254425 @default.
• W2896534168 hasConcept C181389837 @default.
• W2896534168 hasConcept C185592680 @default.
• W2896534168 hasConcept C24890656 @default.
• W2896534168 hasConcept C2777056448 @default.
• W2896534168 hasConcept C2781276175 @default.
• W2896534168 hasConcept C33923547 @default.
• W2896534168 hasConcept C501593827 @default.
• W2896534168 hasConcept C55493867 @default.
• W2896534168 hasConcept C71924100 @default.
• W2896534168 hasConcept C98274493 @default.
• W2896534168 hasConceptScore W2896534168C110121322 @default.
• W2896534168 hasConceptScore W2896534168C112705442 @default.
• W2896534168 hasConceptScore W2896534168C121332964 @default.
• W2896534168 hasConceptScore W2896534168C125287762 @default.
• W2896534168 hasConceptScore W2896534168C134306372 @default.
• W2896534168 hasConceptScore W2896534168C139254425 @default.
• W2896534168 hasConceptScore W2896534168C181389837 @default.
• W2896534168 hasConceptScore W2896534168C185592680 @default.
• W2896534168 hasConceptScore W2896534168C24890656 @default.
• W2896534168 hasConceptScore W2896534168C2777056448 @default.
• W2896534168 hasConceptScore W2896534168C2781276175 @default.
• W2896534168 hasConceptScore W2896534168C33923547 @default.
• W2896534168 hasConceptScore W2896534168C501593827 @default.
• W2896534168 hasConceptScore W2896534168C55493867 @default.
• W2896534168 hasConceptScore W2896534168C71924100 @default.
• W2896534168 hasConceptScore W2896534168C98274493 @default.
• W2896534168 hasIssue "2" @default.
• W2896534168 hasLocation W28965341681 @default.
• W2896534168 hasLocation W28965341682 @default.

• next